Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii
npj Biofilms and Microbiomes · 30.09.2024 · 10 (1)
DOI: 10.1038/s41522-024-00560-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift npj Biofilms and Microbiomes, online erschienen am 30.09.2024. Verfasst von P J Alexander und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, UK. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Microbial Sensitivity Tests, Biofilms, Antimicrobial Peptides. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acinetobacter baumannii is designated by the World Health Organisation as a critical priority pathogen. Previously we discovered antimicrobial peptides (AMPs), namely Lynronne-1, -2 and -3, with efficacy against bacterial pathogens, such as Staphylococcus aureus and Pseudomonas aeruginosa . Here we assessed Lynronne-1, -2 and -3 structure by circular dichroism and efficacy against clinical strains of A. baumannii . All Lynronne AMPs demonstrated alpha-helical secondary structures and had antimicrobial activity towards all tested strains of A. baumannii (Minimum Inhibitory Concentrations 2–128 μg/ml), whilst also having anti-biofilm activity. Lynronne-2 and -3 demonstrated additive effects with amoxicillin and erythromycin, and synergy with gentamicin. The AMPs demonstrated little toxicity towards mammalian cell lines or Galleria mellonella . Fluorescence-based assay data demonstrated that Lynronne-1 and -3 had higher membrane-destabilising action against A. baumannii in comparison with Lynronne-2, which was corroborated by transcriptomic analysis. For the first time, we demonstrate the therapeutic activity of Lynronne AMPs against A. baumannii .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, UK.
- Aix Marseille Univ, CNRS, Centrale Marseille, iSm2 (UMR7313), Marseille, France.
- School of Pharmacy, QUB, Medical Biology Centre, Belfast, UK.
- Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Aberystwyth, UK.
- School of Chemistry and Chemical Engineering, Queen's University Belfast, Belfast, UK.
- Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, UK. s.huws@qub.ac.uk.
ORCID-Profile: L B Oyama, S A Cochrane, M Maresca, S A Huws
Zitieren
APA
Alexander, P. J., Oyama, L. B., Olleik, H., Godoy Santos, F., O'Brien, S., Cookson, A., Cochrane, S. A., Gilmore, B. F., Maresca, M., & Huws, S. A. (2024). Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii. npj Biofilms and Microbiomes, 10(1). https://doi.org/10.1038/s41522-024-00560-2
Vancouver
Alexander PJ, Oyama LB, Olleik H, Godoy Santos F, O'Brien S, Cookson A, et al. Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii. npj Biofilms and Microbiomes. 2024;10(1). doi:10.1038/s41522-024-00560-2
BibTeX
@article{Alexander2024,
author = {Alexander, P J and Oyama, L B and Olleik, H and Godoy Santos, F and O'Brien, S and Cookson, A and Cochrane, S A and Gilmore, B F and Maresca, M and Huws, S A},
title = {Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii},
journal = {npj Biofilms and Microbiomes},
year = {2024},
volume = {10},
number = {1},
doi = {10.1038/s41522-024-00560-2}
}
EUVIMED